Capstone Investment Advisors’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,043
| Closed | -$193K | – | 612 |
|
|
2024
Q4 | $193K | Sell |
1,043
-116
| -10% | -$21.4K | ﹤0.01% | 665 |
|
|
2024
Q3 | $228K | Sell |
1,159
-368
| -24% | -$72.5K | ﹤0.01% | 642 |
|
|
2024
Q2 | $315K | Buy |
1,527
+789
| +107% | +$163K | ﹤0.01% | 749 |
|
|
2024
Q1 | $200K | Buy |
738
+74
| +11% | +$20.1K | ﹤0.01% | 1174 |
|
|
2023
Q4 | $157K | Buy |
+664
| New | +$157K | ﹤0.01% | 893 |
|
|
2023
Q3 | – | Sell |
-198
| Closed | -$41.6K | – | 1134 |
|
|
2023
Q2 | $41.6K | Buy |
198
+20
| +11% | +$4.21K | ﹤0.01% | 825 |
|
|
2023
Q1 | $35.9K | Buy |
+178
| New | +$35.9K | ﹤0.01% | 535 |
|
|
2022
Q2 | – | Sell |
-721
| Closed | -$205K | – | 955 |
|
|
2022
Q1 | $205K | Buy |
+721
| New | +$205K | ﹤0.01% | 675 |
|
|
2021
Q4 | – | Sell |
-413
| Closed | -$170K | – | 853 |
|
|
2021
Q3 | $170K | Buy |
+413
| New | +$170K | ﹤0.01% | 657 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 749 |
|
|
2017
Q2 | – | Sell |
-29,088
| Closed | -$2.62M | – | 577 |
|
|
2017
Q1 | $2.62M | Buy |
+29,088
| New | +$2.62M | 0.07% | 162 |
|
|
2016
Q4 | – | Sell |
-11,852
| Closed | -$987K | – | 734 |
|
|
2016
Q3 | $987K | Buy |
11,852
+1,602
| +16% | +$133K | 0.02% | 287 |
|
|
2016
Q2 | $845K | Sell |
10,250
-7,400
| -42% | -$610K | 0.02% | 302 |
|
|
2016
Q1 | $1.34M | Buy |
+17,650
| New | +$1.34M | 0.04% | 200 |
|